BRPI0512425A - método e composições para inibir, destruir, e/ou inativar vìrus - Google Patents

método e composições para inibir, destruir, e/ou inativar vìrus

Info

Publication number
BRPI0512425A
BRPI0512425A BRPI0512425-5A BRPI0512425A BRPI0512425A BR PI0512425 A BRPI0512425 A BR PI0512425A BR PI0512425 A BRPI0512425 A BR PI0512425A BR PI0512425 A BRPI0512425 A BR PI0512425A
Authority
BR
Brazil
Prior art keywords
destroying
inhibiting
compositions
inactivating viruses
inactivating
Prior art date
Application number
BRPI0512425-5A
Other languages
English (en)
Inventor
Charles A Fust
Kevin S Harrod
Adriana E Kajon
Original Assignee
Sinofresh Healthcare Inc
Lovelace Respiratory Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinofresh Healthcare Inc, Lovelace Respiratory Res Inst filed Critical Sinofresh Healthcare Inc
Publication of BRPI0512425A publication Critical patent/BRPI0512425A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

METODOS E COMPOSIçõES PARA INIBIR, DESTRUIR E/OU INATIVAR VìRUS . A presente descoberta propicia composições, métodos e processos para inibir, destruir e/ou inativar contaminantes virais em um material de fonte biológica, ou tratamento de infecções virais. As composições reveladas incluem um ou mais compostos quartenários de amónio. Um método exemplar inclui o contato do material de fonte biológica com uma solução contendo um ou mais sais quartenários de amónio.
BRPI0512425-5A 2004-07-23 2005-07-25 método e composições para inibir, destruir, e/ou inativar vìrus BRPI0512425A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59078104P 2004-07-23 2004-07-23
US11/187,575 US20060019987A1 (en) 2004-07-23 2005-07-22 Methods and compositions for inhibiting, destroying, and/or inactivating viruses
PCT/US2005/026138 WO2007001323A2 (en) 2004-07-23 2005-07-25 Methods and compositions for inhibiting, destroying, and/or inactivating viruses

Publications (1)

Publication Number Publication Date
BRPI0512425A true BRPI0512425A (pt) 2008-03-04

Family

ID=35658102

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512425-5A BRPI0512425A (pt) 2004-07-23 2005-07-25 método e composições para inibir, destruir, e/ou inativar vìrus

Country Status (9)

Country Link
US (1) US20060019987A1 (pt)
EP (1) EP1778232A2 (pt)
JP (1) JP2008507583A (pt)
KR (1) KR20070048199A (pt)
AU (1) AU2005333685A1 (pt)
BR (1) BRPI0512425A (pt)
CA (1) CA2578108A1 (pt)
IL (1) IL180879A0 (pt)
WO (1) WO2007001323A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043253A1 (en) * 2003-08-19 2005-02-24 Cook Bradley R. Use of wound healing compositions for prevention of infections and allergies
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
JP5108334B2 (ja) * 2007-03-05 2012-12-26 タマ化学工業株式会社 抗ウイルス剤
JP5255495B2 (ja) * 2009-03-19 2013-08-07 ディバーシー株式会社 殺カリシウイルス剤組成物およびその使用方法
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
JP6901824B2 (ja) * 2013-01-04 2021-07-14 アームズ ファーマシューティカル エルエルシーＡｒｍｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｌｌｃ． 微生物により引き起こされる若しくは悪化する疾患の治療方法、又はその症状の緩和方法
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
ITRA20130015A1 (it) * 2013-06-12 2014-12-13 No & C Composto finalizzato al miglioramento della respirazione
KR102200507B1 (ko) * 2019-12-11 2021-01-08 주식회사 아워홈 바이러스 소독용 조성물
KR102330342B1 (ko) * 2020-03-02 2021-11-23 경희대학교 산학협력단 감염성 호흡기 바이러스 차단용 조성물 및 이의 용도
WO2022053194A1 (en) * 2020-09-08 2022-03-17 Unilever Ip Holdings B.V. Oral care compositions
JP7421216B2 (ja) * 2020-10-28 2024-01-24 日本ゼトック株式会社 複合材料およびその製造方法
CN116076514B (zh) * 2022-12-02 2023-12-22 苏州良辰生物医药科技有限公司 一种用于灭活脂包膜病毒的病毒灭活剂及灭活方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1823094A (en) * 1930-01-27 1931-09-15 Dylong John Inhaler
US1804670A (en) * 1930-04-11 1931-05-12 Nasalets Inc Nasal pellet
US2237954A (en) * 1939-06-30 1941-04-08 William R Wilson Nasal filter and inhaler
US2356062A (en) * 1942-02-03 1944-08-15 Latimer Lab Inc Therapeutic composition
US2660166A (en) * 1951-01-18 1953-11-24 Malcolm A Coleman Nasal filter
US3145711A (en) * 1961-12-08 1964-08-25 Beber Arthur Disposable nasal filter
US3457917A (en) * 1966-02-17 1969-07-29 John A Mercurio Nasal filtering device
US3463149A (en) * 1968-07-05 1969-08-26 Theodor Albu Nose air filter
US3828577A (en) * 1972-04-19 1974-08-13 G Haynes Nose ornament and sachet
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US4769171A (en) * 1987-05-11 1988-09-06 Harlmen, Inc. Liquid ear cleansing composition
CH678151A5 (en) * 1988-07-13 1991-08-15 Heinz Hermann Weick Self-medication nasal dispenser
US5175152A (en) * 1990-09-28 1992-12-29 Singh Nikhilesh N Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US5288492A (en) * 1992-11-13 1994-02-22 Morris Michael A Decongestant composition containing aloe vera
ATE168265T1 (de) * 1993-04-30 1998-08-15 Procter & Gamble Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
US5378465A (en) * 1993-05-24 1995-01-03 Zeines; Victor Solution for application to an oral cavity
US5489435A (en) * 1993-07-06 1996-02-06 Ratcliff; Perry A. Composition for treatment of abnormal conditions of the epithelium of bodily orifices
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
NZ309624A (en) * 1995-06-06 1999-04-29 Bayer Ag Non-irritating, non-sensitizing, non-ototoxic (harmful to the ears) antibacterial compositions
US6344210B2 (en) * 1996-05-10 2002-02-05 Charles A. Fust Composition for freshening nostrils and sinus cavities
BR9914813A (pt) * 1998-10-27 2001-07-03 Alcon Lab Inc Sistema conservante para composições farmacêuticas administráveis topicamente
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
JP2003510263A (ja) * 1999-09-24 2003-03-18 アルコン，インコーポレイテッド シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物

Also Published As

Publication number Publication date
KR20070048199A (ko) 2007-05-08
CA2578108A1 (en) 2007-01-04
US20060019987A1 (en) 2006-01-26
WO2007001323A2 (en) 2007-01-04
WO2007001323A3 (en) 2007-11-22
IL180879A0 (en) 2008-04-13
EP1778232A2 (en) 2007-05-02
AU2005333685A1 (en) 2007-01-04
JP2008507583A (ja) 2008-03-13

Similar Documents

Publication Publication Date Title
BRPI0512425A (pt) método e composições para inibir, destruir, e/ou inativar vìrus
Ge et al. Identification of soil bacteria susceptible to TiO2 and ZnO nanoparticles
BRPI0814939A2 (pt) Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero.
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
WO2007120556A3 (en) Antiviral methods
CY1118905T1 (el) Καθαρισμος καψικων σακχαριδιων staphylococcus aureus τυπου 5 και τυπου 8
BRPI0520165A2 (pt) placa àssea e mÉtodo para usar a placa àssea
BR112012010270A2 (pt) mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
BR112014005543A2 (pt) sistema de descarte de medicação geral
BR112014013606A8 (pt) método e dispositivo para distribuir armazenamentos de código e de dados entre memória volátil e memória não volátil
BRPI0815707A2 (pt) Processo para a liquefação de uma corrente gasosa, e, sistema para o tratamento de uma corrente de alimentação gasosa.
WO2007127006A3 (en) Sterilization methods and systems
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
BRPI0516727A (pt) métodos para tratar um linfoma positivo em cd30 , para inibir o crescimento de uma célula que expressa cd30, e para tratar ou prevenir uma doença
BRPI0821078A2 (pt) Desnatadores ('creamers") livres de proteína, sistemas estabilizantes, e processo de produção dos mesmos
BR112014012729A8 (pt) processo para tratamento de água residual de coque
AR061016A1 (es) Proceso para la purificacion de anastrozol
BR112015016614A2 (pt) métodos e sistemas de tratamento de água residual
BR112014007216A2 (pt) métodos e sistemas para autenticar e rastrear objetos
ATE539771T1 (de) Vorrichtung zur plasmabeschichtung/sterilisation
WO2015017338A3 (en) Treatment of beverages to reduce the effects of noxious constituents
BRPI0612124A2 (pt) derivados de heteroarila para o tratamento de viroses
BR112017019337A2 (pt) tratamento de dor
ATE536925T1 (de) Dekontaminierungsformulierungen
WO2009023846A3 (en) Methods for heat shock protein dependent cancer treatment

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.